Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arch Pharmalabs files IPO papers with SEBI
MoneyControl, India
Sunday, March 27, 2011 - 12:13pm
tags:
Arch Pharmalabs, bipolar disorder
Top 5 Pharmaceuticals Paying Excellent Dividends
Seeking Alpha
Sunday, March 27, 2011 - 12:10pm
tags:
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novartis, Pfizer
Cephalon Beefs Up Cancer Pipeline, Sanofi Bolsters Collaborative Activities
Seeking Alpha
Sunday, March 27, 2011 - 12:09pm
tags:
Cephalon, Sanofi, Gemin X, obatoclax, small cell lung cancer, Fovea
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Seeking Alpha
Sunday, March 27, 2011 - 11:39am
tags:
ipilimumab, monoclonal antibodies, immunotherapy, Yervoy, Bristol-Myers Squibb, melanoma
Coming: Radically Shrunken Pfizer?
Barron's
Saturday, March 26, 2011 - 3:38pm
tags:
Pfizer
Federal Circuit: Cross-appeal by Apotex an 'egregious' attempt to 'game the system'
Law.com
Saturday, March 26, 2011 - 3:35pm
tags:
Apotex, Sanofi, Taxotere, lawsuits, Hospira
Urigen Operational Progress Report
The Street
Saturday, March 26, 2011 - 10:23am
tags:
Urigen Pharmaceuticals
Biostar Pharmaceuticals (BSPM) Posts Solid Q4, FY Earnings
International Business Times
Saturday, March 26, 2011 - 10:21am
tags:
Biostar Pharmaceuticals
Watson Confirms OxyContin® Patent Challenge
PR NewsWire
Saturday, March 26, 2011 - 10:20am
tags:
Watson Pharmaceuticals, oxycontin
China to Account for 25% of Merck Sales by 2013: CEO
CNBC
Saturday, March 26, 2011 - 10:15am
tags:
Merck, China
R&D can pay, Bristol-Myers CEO says
WSJ
Saturday, March 26, 2011 - 10:15am
tags:
Bristol-Myers Squibb
ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
Yahoo/BusinessWire
Saturday, March 26, 2011 - 10:10am
tags:
Merck, Zostavax, shingles
Pfile Pfizer Under "Potential"
Motley Fool
Saturday, March 26, 2011 - 10:09am
tags:
Pfizer
Bristol-Myers shares jump on drug approval
MarketWatch
Saturday, March 26, 2011 - 10:08am
tags:
Bristol-Myers Squibb
DARA BioSciences Filing Shelf Registration Statement to Replace Expiring Registration Statement
Yahoo/GlobeNewsWire
Saturday, March 26, 2011 - 10:06am
tags:
DARA Biosciences
Make Money in Pharmaceuticals the Easy Way (ETFs)
Motley Fool
Saturday, March 26, 2011 - 10:05am
tags:
Health care lobbying boom continues
CNN Money
Saturday, March 26, 2011 - 10:04am
tags:
health care reform
Does Amgen Measure Up?
Motley Fool
Saturday, March 26, 2011 - 10:02am
tags:
Amgen
Bottom Fishing in Biotech
Forbes
Saturday, March 26, 2011 - 10:00am
tags:
Biotech Stock Mailbag: Bio-Hazards
The Street
Saturday, March 26, 2011 - 10:00am
tags:
Telik, Xoma, Genta, Cell Therapeutics, Discovery Labs, Cel-Sci

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.